Aug 12, 2025, 01:00 AM by User Not Found

Bio-IT World | The pharma industry excels at collaborating with startup companies and scaling up the production of drugs and biologics, but they may be missing the big-picture perspective of the U.S. government as well as some of the cutting-edge research happening within academia. It’s a problematic norm that needs addressing if artificial intelligence (AI) is to benefit drug discovery and diagnostics as well as healthcare delivery in terms of safety, equity, and effectiveness.

Aug 11, 2025, 09:09 AM by

Memorial Healthcare System Deploys Population Health Technology to Drive Medication Adherence

Aug 8, 2025, 11:50 AM by

Aug 8, 2025, 11:50 AM by

Aug 7, 2025, 09:00 AM by

Accessible, patient-focused & CMS-required medication instructions save nurses time during inpatient care, while improving HCAHPS scores for patient satisfaction

Aug 7, 2025, 09:00 AM by

LabConnect has officially completed the global deployment of LIMSConnect, its internal name for the enterprise-wide implementation of Sapio LIMS, across more than 30 locations on six continents. Built on Sapio’s configurable, AI-enabled lab informatics platform, LIMSConnect unifies complex sample workflows, improves data integrity, and enables scalable innovation across LabConnect’s central laboratory network.

Aug 7, 2025, 09:00 AM by

Biocair, an established global leader in life science logistics, announced the further expansion of its operations in the APAC region with the opening of a new office in Shanghai, China.

Aug 7, 2025, 01:00 AM by User Not Found

Bio-IT World | Russia plans to significantly expand its national database of genetic information by 2030 according to a recent decree approved by the Russian government. As part of the plans, the volume of the already existing database will be increased by 35 times and reach 35 petabytes by 2030.

Aug 6, 2025, 09:11 AM by

Supreme Group Acquires Pivot Design, Marking a Significant Expansion in Pharma and Rare Disease

Aug 6, 2025, 09:11 AM by

Alfa Chemistry has launched a new portfolio of food surfactants designed to improve stability, texture, and processing efficiency in modern food manufacturing, supporting clean-label and plant-based formulation trends.

Aug 6, 2025, 09:11 AM by

Aug 6, 2025, 09:11 AM by

VieCure adds Summit Cancer Centers to community oncology care network.

Aug 6, 2025, 01:00 AM by User Not Found

Bio-IT World | The Alzheimer's Association International Conference was held last week in Toronto and researchers and companies gathered to present their progress in the fight to diagnose and treat Alzheimer’s disease. Among the timely new developments: new products from Quanterix; pre-clinical data from AltPep, OncoC4, and NKGen Biotech; pipeline updates from Eisai, Biogen, and Roche; and more.

Aug 5, 2025, 09:17 AM by

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a research collaboration with Syntekabio, Inc., a leading artificial intelligence (AI)-driven drug discovery company, to identify additional disease targets and optimize the therapeutic profile of DA-1241, MetaVia’s novel oral G-Protein-Coupled Receptor 119 (GPR119) agonist.

Aug 5, 2025, 09:17 AM by

• Investment in premises on Cambridge Technopark reflects significant milestone in the Company’s growth • Relocation increases logistics and R&D capacity, enabling faster customization and turnaround, strengthening order fulfilment to better support customers in their research and development efforts

Aug 5, 2025, 09:17 AM by

Former Covera Health CTO to lead technology and product strategy at Advarra, driving innovation in clinical research

Aug 5, 2025, 09:17 AM by

Aug 5, 2025, 09:17 AM by

New research from the COPD Foundation and Phreesia shows patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a critical role in helping patients understand their condition, set realistic goals, ease symptom burden and improve their quality of life.

Aug 5, 2025, 09:17 AM by

I wanted to share that Software-as-a-Service (SaaS) security leader, AppOmni today announced new innovations to combat rising AI and SaaS risks for healthcare companies: https://appomni.com/press-releases/saas-ai-security-innovation Please let me know if you’d like to speak with them for more about the benefits for healthcare, get a product image, or if I can provide anything further. The rapid adoption of AI has introduced a new and complex attack surface that healthcare cybersecurity teams must manage. AI is an active participant in the SaaS environment; whether embedded in SaaS platforms (such as M365 or Google Workspace) or acting as agents, AI tools constantly access and process sensitive data across the SaaS estate. Healthcare organizations need the ability to identify unsanctioned or shadow AI and SaaS usage, as well as practical strategies to control and monitor AI usage. AppOmni is defining the future of SaaS and AI security by arming organizations of all sizes with the end-to-end controls needed for safe usage of these applications, helping them identify critical risks, protect sensitive data, detect abnormal behavior, and respond to evolving threats. The new features help healthcare understand their risk exposure to AI and implement controls to secure them by identifying both sanctioned and unsanctioned/ shadow AI apps, including AI embedded within SaaS applications. It’s also adding support for 30 new AI and SaaS applications, including ChatGPT Enterprise, Claude, OpenAI, and Anthropic, Cisco Umbrella, Cisco Secure Access, and Gong. And it’s giving healthcare organizations a free 90-day trial of its new AppOmni Foundations package – a SaaS security starter solution for organizations that need to discover shadow SaaS and AI, app users and permission, and detect threats and anomalous activities.

Aug 5, 2025, 09:17 AM by

InSysBio announces Immune Response Template (IRT) which was previously available under a license model now is completely free to use. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system.